9 | HS&M JANUARY/FEBRUARY 2016
UCB chief emphasizes the importance of making an impact
and delivering value
Jean-Christophe Tellier, CEo of UCB, speaks to paul Simms, eyeforpharma chairman,
about UCB’s future direction and the significance of culture.
“First of all, I’m a physician,” he tells eyeforpharma. “A
rheumatologist, trying to create an impact and deliver
value for patients. In a sense, I’ve always been there.
The physician and the pharma industry are really
partners to create value for patients.”
Focused on two key therapy areas—immunology and
€ 3. 3;billion;in;2014.
expanding its executive committee and creating what